Phenotypic and genomic characterization of Levilactobacillus brevis YT108: a potential probiotic strain capable of metabolizing xylo-oligosaccharides
Letters in Applied Microbiology · 2025
DOI: 10.1093/lambio/ovaf014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2025. Verfasst von Yang Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Sichuan Normal University, Chengdu 610101, China. Hauptthemen laut MEDLINE: Probiotics, Oligosaccharides, Glucuronates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Solid-state Fermentation Resource Utilization Key Laboratory of Sichuan Province, Science and Technology Planning Project of Ganzi Prefecture, Panxi Crops Research and Utilization Key Laboratory of Sichuan Province.
Abstract (Originalsprache)
Levilactobacillus brevis YT108, identified for its ability to metabolize prebiotic xylo-oligosaccharides (XOS), emerges as a candidate for probiotic use in synbiotic food formulations. This study aimed to investigate the metabolic and genomic traits associated with XOS metabolism in YT108 and to assess its probiotic attributes through whole genome sequencing and in vitro assays. Strain YT108 exhibited robust growth kinetics on XOS as the sole carbon source, with a growth profile comparable to that on glucose, achieving a pH reduction to 4.68 and an OD600nm of 1.603 after 48 h. Three key gene clusters (xylCDEPFRT, xylHTG, and xylABT) and key enzymes (1,4-β-xylosidase) were identified as potentially involved in XOS metabolism. In vitro assays confirmed the strain’s remarkable physiological properties, including tolerance to acid, bile, heat, and NaCl, as well as resistance to simulated gastrointestinal juices and antioxidant capacity. Furthermore, strain YT108 was sensitive to five commonly used antibiotics and lacked transferable resistance genes. Taken together, these results highlight the potential of L. brevis YT108 as a probiotic candidate with beneficial traits for XOS utilization, suggesting its promising application in the formulation of next-generation synbiotic products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science, Sichuan Normal University, Chengdu 610101, China.
- Chengdu Academy of Agriculture and Forestry Sciences, Chengdu 611130, China.
- Key Laboratory of the Evaluation and Monitoring of Southwest Land Resources (Ministry of Education), Sichuan Normal University, Chengdu 610066, China.
- Panxi Crops Research and Utilization Key Laboratory of Sichuan Province, Xichang University, Liangshan 615013, China.
Förderung
- Solid-state Fermentation Resource Utilization Key Laboratory of Sichuan Province
- Science and Technology Planning Project of Ganzi Prefecture
- Panxi Crops Research and Utilization Key Laboratory of Sichuan Province
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Chen, Y., Zhou, J., Li, X., Li, X. Y., Qiu, S. X., Xu, Z. Y., Yang, J. X., Zhu, Y. T., Zhang, X. R., & Yan, L. (2025). Phenotypic and genomic characterization of Levilactobacillus brevis YT108: a potential probiotic strain capable of metabolizing xylo-oligosaccharides. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovaf014
Vancouver
Chen Y, Zhou J, Li X, Li XY, Qiu SX, Xu ZY, et al. Phenotypic and genomic characterization of Levilactobacillus brevis YT108: a potential probiotic strain capable of metabolizing xylo-oligosaccharides. Letters in Applied Microbiology. 2025. doi:10.1093/lambio/ovaf014
BibTeX
@article{Chen2025,
author = {Chen, Yang and Zhou, Jun and Li, Xin and Li, Xin-Yao and Qiu, Shi-Xiu and Xu, Zhen-Ying and Yang, Jian-Xia and Zhu, Yuan-Ting and Zhang, Xin-Rui and Yan, Lang},
title = {Phenotypic and genomic characterization of Levilactobacillus brevis YT108: a potential probiotic strain capable of metabolizing xylo-oligosaccharides},
journal = {Letters in Applied Microbiology},
year = {2025},
doi = {10.1093/lambio/ovaf014}
}
EUVIMED